title: Successful management of chronic gastrointestinal hemorrhage using bevacizumab in the setting of hereditary hemorrhagic telangiectasia.
authors: Division of Hematology-Oncology, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, California.
authors: Mary E
authors: ME
authors: Sehl
authors: Division of Hematology-Oncology, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, California.
authors: Theresa
authors: T
authors: M Gruber
authors: Department of Radiology, David Geffen School of Medicine, University of California, Los Angeles, California.
authors: Justin P
authors: JP
authors: McWilliams
authors: Division of Hematology-Oncology, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, California.
authors: Victor J
authors: VJ
authors: Marder
mesh_terms: D000368:Aged; D020533:Angiogenesis Inhibitors / Q000008:administration & dosage*; D061067:Antibodies, Monoclonal, Humanized / Q000008:administration & dosage*; D000068258:Bevacizumab; D006471:Gastrointestinal Hemorrhage / Q000097:blood / Q000188:drug therapy*; D006801:Humans; D008297:Male; D013683:Telangiectasia, Hereditary Hemorrhagic / Q000097:blood / Q000188:drug therapy*
chemical_list: D020533:Angiogenesis Inhibitors; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab